Alnylam Pharmaceuticals Inc (1ALNY)
Market Closed
17 Jul, 15:30
€
249. 10
0
0%
€
45.82B Market Cap
- P/E Ratio
- Div Yield
54 Volume
-3.56 Eps
€ 249.1
Previous Close Want to track 1ALNY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alnylam Pharmaceuticals Inc (1ALNY) Statistics
Valuation metrics
Market Cap 45.82B
Enterprise value 28.42B
Trailing P/E (ttm) 73.79
Forward P/E -
PEG ratio -0.16
Price/Sales (ttm) 7.88
Price/Book (mrq) 36.5
Enterprise Value/Revenue 7.72
Enterprise Value/EBITDA 41.03
Overview
Shares outstanding 133.44M
Float 132.96M
Shares short -
% Held by insiders 0%
% Held by institutions 1.02%
Average volume (10 days) 1
Average volume (90 days) 11
Price summary
52-Week low 221
52-Week high 439.6
Beta 0.3
50-Day moving average 268.82
200-Day moving average 334.54
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.13%
Operating margin 0.23%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.9%
Income Statement
Revenue (ttm) 3.68B
Revenue per share (ttm) 32.52
Quarterly revenue growth (yoy) 0.96%
Gross profit (ttm) 2.97B
EBITDA 909.4M
Net income to common (ttm) 461.72M
Diluted EPS (ttm) 3.43
Quarterly earnings growth (yoy) 0.96%
Balance Sheet
Total cash (mrq) 2.58B
Total cash per share (mrq) 22.54
Total debt (mrq) 2.55B
Total Debt/Equity (mrq) 276.2
Current ratio (mrq) 3.13%
Book value per share (mrq) 6.93
Cash Flow
Cash flow statement 613.55M
Levered free cash flow (LFCF) 175.69M
